Discover 1,123 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,123
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
for
Hematopoietic Cell Transplant, Solid Organ Transplant,
Location: Boston MA, The Bronx NY, Washington D.C. DC, Miami FL,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0 - 18
Code: NCT05550298
Recruiting
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Location: The Bronx NY, Norfolk VA, Rockville MD, Miami FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 6 - 17
Code: NCT05723198
Phase 3, Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
for
Ovarian Cancer, Non-small Cell Lung Cancer
Location: Boston MA, New York NY, East Brunswick NJ, Fairfax VA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06303505
Phase 1, Phase 2, Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Scarborough ME, Boston MA, Hartford CT, Sherbrooke,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT06064097
Phase 2, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: North Dartmouth MA, Quebec, Toms River NJ,
Sponsor: AstraZeneca
Sex: All
Age: 40 - 70+
Code: NCT06883305
Phase 3, Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Abington PA, Wyomissing PA, Miami FL, Winter Park FL,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT06767683
Phase 2, Phase 3, Recruiting
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
for
Hepatocellular Carcinoma (HCC)
Location: New York NY, Baltimore MD, Charlottesville VA,
Sponsor: RayzeBio, Inc.
Sex: All
Age: 18+
Code: NCT06726161
Phase 1, Phase 2, Recruiting
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
for
Idiopathic Pulmonary Fibrosis (IPF)
Location: Philadelphia PA, Winston-Salem NC, Orlando FL,
Sponsor: InSilico Medicine Hong Kong Limited
Sex: All
Age: 40+
Code: NCT05975983
Phase 2, Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Saint Johnsbury VT, Lebanon NH, Lake Success NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04510597
Phase 3, Recruiting
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: New York NY, Hackensack NJ, Miami FL, Toronto,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT04973605
Phase 1, Phase 2, Recruiting
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
for
Acute Hepatic Porphyria
Location: Boston MA, New York NY, Baltimore MD, Birmingham AL,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 12+
Code: NCT04883905
Recruiting
MYLUNG Consortium Part 3: Observational Study
for
Carcinoma, Non-Small-Cell Lung
Location: Albany NY, Newport News VA, Palm Bay FL, Blacksburg VA,
Sponsor: US Oncology Research
Sex: All
Age: 18+
Code: NCT05885698
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for
End Stage Kidney Disease
Location: Halifax, Portsmouth NH, Boston MA, East Providence RI,
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT05485961
Phase 2, Phase 3, Recruiting
Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND